Sangamo Biosciences Short Ratio

$7.25  0.04  0.55%
Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Sangamo Biosciences 
Short Ratio 
Short Interest 
Average Trading Volume 
9.45 times

About Short Ratio

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Compare Sangamo Biosciences to competition

Sangamo Biosciences Short Ratio Assessment

Benchmark  Embed   Sangamo Biosciences Comparables 
Based on latest financial disclosure Sangamo Biosciences Inc has Short Ratio of 9.45 times. This is 139.24% higher than that of the Healthcare sector, and 130.49% higher than that of Biotechnology industry, The Short Ratio for all stocks is 323.77% lower than the firm.

Filter other Stocks by Short Ratio

Short Ratio Input Range 
Click to run this filter
Filter Other Equities
Found 10 equities

Short Ratio

GILD NMSGilead Sciences Inc
2.38 times
2.65 times
CELG NMSCelgene Corporation
2.48 times
BIIB NMSBiogen Idec Inc
1.27 times
REGN NMSRegeneron Pharmaceuticals Inc
3.66 times
ALXN NMSAlexion Pharmaceuticals Inc
3.39 times
VRTX NMSVertex Pharmaceuticals Incorporated
2.39 times
BXLT NYSEBaxalta Inc
1.85 times
ILMN NMSIllumina Inc
1.81 times
INCY NMSIncyte Corporation
1.43 times
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  

Short Ratio Comparison

Short Ratio  
Benchmark  Embed   Sangamo Biosciences Comparables 
Sangamo Biosciences is currently under evaluation in short ratio category among related companies.
NameSangamo Biosciences Inc
InstrumentUSA Stock
Analyst ConsensusStrong Buy 6 Opinions
Risk-adjusted AdviceHold Under Valued
CurrencyUSD - US Dollar
DescriptionSangamo BioSciences Inc. a clinical stage biopharmaceutical company focused on the research development and commercialization of engineered DNAbinding proteins as novel therapeutic solutions for various monogenic and infectious diseases with unmet medical needs. more

Other Sangamo Biosciences Fundamentals

Return On Equity(14.99) %
Return On Asset(9.24) %
Profit Margin(68.35) %
Operating Margin(78.21) %
Current Valuation301.82 M
Shares Outstanding70.05 M
Shares Owned by Insiders4.18 %
Shares Owned by Institutions71.00 %
Number of Shares Shorted11.67 M
Price to Book2.49 times
Price to Sales11.19 times
Revenue45.37 M
Gross Profit45.87 M
EBITDA(34.59 M)
Net Income(31.01 M)
Cash and Equivalents219.33 M
Cash per Share3.13 times
Current Ratio10.29 times
Book Value Per Share2.91 times
Cash Flow from Operations(27.33 M)
Short Ratio9.45 times
One Year High19.25
One Year Low5.3
Earnings Per Share(0.45) times
Number of Employees102
Market Capitalization519.05 M
Total Asset232.52 M
Retained Earnings(355.24 M)
Working Capital119.14 M
Current Asset227.68 M
Current Liabilities22.13 M
Z Score-1.4